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Abstract
Using multiple quantitative analyses, we discovered microRNAs (miRNAs) abundantly expressed
in visual cortex that respond to dark-rearing (DR) and/or monocular deprivation (MD). The most
significantly altered miRNA, miR-132, was rapidly upregulated after eye-opening and delayed by
DR. In vivo inhibition of miR-132 prevented ocular dominance plasticity in identified neurons
following MD, and affected maturation of dendritic spines, demonstrating its critical role in the
plasticity of visual cortex circuits.
MiRNAs are small non-coding RNAs that are known to orchestrate the expression of protein
coding genes1. They are particularly enriched in the nervous system, and have been shown
to influence neuronal development and function2-4. However, little is known about their role
in experience-dependent cortical plasticity. Here, we have used molecular analyses to
discover changes in the expression of miRNAs in the primary visual cortex (V1) of mice
that were visually deprived5,6, either by dark rearing (DR) with complete absence of light
from birth, or by monocular deprivation (MD) with suture of one eyelid during the ‘critical
period’ of heightened ocular dominance plasticity7. We show that the expression of a subset
of miRNAs is significantly altered by visual deprivation. Moreover, we demonstrate with
structural and functional analyses that the most robustly experience-dependent miRNA,
miR-132, is a crucial regulator of visual cortex plasticity.
In order to screen for miRNAs that respond to visual deprivation, we compared their
expression in RNA extracted from V1 of three groups of mice that were age-matched to the
peak of the critical period5: P28 control mice reared with a normal light/dark cycle, P28 DR
mice reared in darkness from birth, and P28 MD mice reared with their eyelid sutured from
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P24-28 (Supplementary Methods and Supplementary Fig. 1). All animal experiments were
approved by the Massachusetts Institute of Technology Institutional Animal Care and Use
Committee (IACUC). Statistical analysis of microarray data (SAM)8 revealed 21
differentially expressed miRNAs, the majority of which were affected in a similar manner
by DR and MD (Supplementary Figs. 1-3 and Supplementary Table 1). Next, we applied
mature miRNA-specific quantitative real-time polymerase chain reaction (qRT-PCR) to a
larger set of DR and MD samples and independently detected 19 of the miRNAs
differentially expressed according to microarray (Fig 1a). Overall, miRNA qRT-PCR and
microarray results were significantly correlated (Supplementary Fig. 4a). qRT-PCR
confirmed nine significantly altered miRNAs, with decreases in miR-132, miR-212 and
miR-690 and increases in miR-497 and miR-551b expression observed after both DR and
MD (Fig. 1a). Expression of two control brain-enriched miRNAs (miR-124a and miR-125b)
was unaffected, in agreement with microarray results (Fig. 1a). Furthermore, no significant
changes were observed in the ipsilateral V1 areas of MD-altered miRNAs (Supplementary
Fig. 4b). In addition, qRT-PCR specific for primary miRNA precursors (pri-miRNAs)
indicated that their changes mirrored those in mature for six out of nine miRNAs, suggestive
of a transcriptional mechanism (Supplementary Fig. 5). We also combined in silico miRNA
target prediction and pathway analysis and found that multiple pathways linked to synaptic
plasticity were predicted to be highly targeted by experience-dependent miRNAs
(Supplementary Tables 2 and 3). Thus, microarray and qRT-PCR analyses together revealed
a set of miRNAs in V1 that are reliably regulated by visual experience, and are predicted to
target plasticity-related molecular pathways.
Focusing on the most highly affected miRNA, miR-132, we demonstrated using qRT-PCR
that it is robustly increased after eye-opening and through the critical period for ocular
dominance plasticity, and that its diminished expression after DR is gradually normalized
after light exposure (Fig. 1b). Furthermore, using locked nucleic acid (LNA) in situ
hybridization, we found that expression of miR-132 was reduced in cortical layers 2-4 of V1
after both DR and MD (Fig. 1c-d and Supplementary Figs. 6 and 7), which are sites of rapid
ocular dominance plasticity9. Given these observations, we reasoned that miR-132 is well
positioned to orchestrate the molecular components of experience-dependent plasticity in
V1.
In order to manipulate miR-132 function in vivo, we injected wild type or GFP-S mice with
a mCherry-miR-132 sponge-expressing lentivirus that predominantly infects neurons and
results in specific “sequestering” of endogenous miR-1324,10 (Supplementary Fig. 8). We
then measured levels of p250GAP, a GTPase targeted by miR-132 known to affect spine
growth and morphology11-13, and examined structural changes in transfected pyramidal
neurons at P28. We found increased levels of p250GAP in mCherry-miR-132 sponge-
expressing pyramidal neurons, and reduced spine density, despite normal neuronal size and
arborization of sponge-infected neurons after both P5 and P16 injections (Fig. 2a-i and
Supplementary Fig. 9a-i). Examination of the changes in spine morphology revealed that
miR-132 inhibition resulted in more immature spines (Fig. 2j), mainly by reducing the
percentage of mushroom spines and increasing the proportion of immature filopodia
(Supplementary Fig. 9j). We assayed for accompanying physiological synaptic changes in
sponge-infected neurons by measuring AMPA receptor-dependent spontaneous miniature
excitatory postsynaptic currents (mEPSCs), using whole-cell recordings from layer 2/3
pyramidal neurons (Fig. 2k-m). Our results showed no changes in mEPSC frequency, yet a
significant reduction in mEPSC amplitude in sponge-infected neurons (Fig. 2n-o). These
effects of miR-132 inhibition are consistent with delayed synaptic maturation of pyramidal
V1 neurons.
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To directly examine the influence of miR-132 on ocular dominance plasticity, we used two-
photon calcium imaging to measure the strength of neuronal responses to contralateral and
ipsilateral eye stimulation in the binocular area of V1, contralateral to the deprived eye,
following neonatal injection of mCherry-miR-132 sponge-expressing virus (Fig. 3a). The
relative strength of contralateral and ipsilateral eye-driven responses was quantified by
calculating the ocular dominance index (ODI) for each neuron (Fig. 3b). Our results
demonstrated that in vivo miR-132 inhibition disrupted the ocular dominance shift that is
normally present after four days of MD (Fig. 3c,d). Analysis of eye-specific responses
showed that the observed blockade of plasticity was mainly due to prevention of MD effects
on contralateral responses (Supplementary Figs. 10 and 11). As expected, neurons that were
transfected with the control virus (containing mCherry without the miR-132 sponge
sequence) did show a shift in ocular dominance towards the non-deprived eye (Fig. 3c,d).
Notably, low miR-132 sponge-expressing neurons (as judged by mCherry load) that were
present in the proximity of higher expressing neurons displayed a shift in their ODI
comparable to control MD animals (Supplementary Fig. 12a-d), as did non-infected neurons
located adjacent to sponge-infected ones (Supplementary Fig. 12e), suggesting a potential
threshold for the degree of miR-132 inhibition needed to abrogate ocular dominance
plasticity. Thus, miR-132 expression in V1 neurons is essential for plasticity of their
responses and underlying circuits.
Ocular dominance plasticity following MD during the critical period leads to coordinated
changes in functional responses of neurons and structural properties of spines7,14,15. Since
miR-132 is upregulated after eye-opening through a time window that parallels the critical
period, and dark-rearing prevents this upregulation, we hypothesize that light- and hence
activity-induced elevation of miR-132 expression is crucial for the initiation of ocular
dominance plasticity. Indeed, sequestering miR-132 levels before eye-opening and
extending through the critical period prevents both MD-induced functional plasticity and
structural maturation of spines. Thus the failure of miR-132 sponge-expressing neurons to
exhibit ocular dominance plasticity at P28 likely reflects a shift of the critical period to a
later age, effectively by maintaining the cortex in a prior developmental stage. We conclude
that experience-dependent upregulation of miR-132 contributes fundamentally to the
sensitive period of cortical plasticity.
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Experience-dependent miRNAs in mouse visual cortex, and detailed analysis of miR-132.
(a) Graph showing mean ± S.E.M. relative to control DR and MD ratios with mature
miRNA-specific qRT-PCR. One asterisk denotes P < 0.05 and two asterisks P < 0.01, based
on two-tailed one-sample Student's t test. (b) Graph showing mean ± S.E.M. relative
miRNA levels (normalized to control P28 mean) based on mature miRNA-specific qRT-
PCR during development of V1, as well as after different durations of light exposure in DR
mice. One asterisk denotes P < 0.05, and two asterisks P < 0.01, based on ANOVA with
Dunnett's test for multiple comparisons relative to control P28. (c) Representative images
from LNA in situ hybridization of miR-132 in V1 at P28 in control, DR, and MD cases both
contralateral (MDc) and ipsilateral (MDi) to the sutured eye. (d) LNA in situ hybridization
for miR-132 in the medial edge of contralateral V1 (marked by dotted line).
Mellios et al. Page 5














Structural and electrophysiological effects of miR-132 inhibition. (a-c) Expression of (a)
p250GAP, (b) mCherry, as well as their (c) co-localization in mCherry-miR-132 sponge-
expressing neurons. DAPI staining is seen in blue in (c). Scale bars = 25 μm. (d-e) Confocal
microscope images from GFP-S transgenic mice showing layer 5 mCherry-miR-132 sponge-
expressing neurons. mCherry expression is shown in (d), and co-localization with GFP in
(e). White arrows point to mCherry and GFP positive neuron used for structural analysis.
Scale bar = 50 μm. (f-g) Representative confocal images from secondary dendritic branches
of (f) control and (g) miR-132 sponge-infected layer 5 pyramidal neurons used for spine
analysis. Scale bar = 5 μm. (h-j) Results (all shown as mean ± S.E.M.) from analysis of (h)
dendritic arborization (Sholl analysis), (i) spine density, and (j) spine morphology of
sponge-infected and control neurons. One asterisk denotes P < 0.05 and two asterisks P <
0.01, based on two-tailed Student's t test. (k) DIC image showing whole-cell patched
pyramidal neuron (arrow) in layer 2/3 of mouse V1. Shadow of patch pipette marked by
white open arrow. Scale bar = 20 μm. (l) Image of the same slice showing miR-132 sponge-
infected cells (arrows). Scale bar = 40 μm. (m) Representative traces showing mEPSCs
recorded from miR-132 sponge-infected and non-infected cells (shown in black and gray,
respectively). Scale bar denotes 20 pA, 0.5 sec. (n-o) Histogram showing (n) mean ± S.E.M.
amplitude and (o) frequency of mEPSCs recorded from control non-infected (gray) and
infected neurons (black; n=9 neurons per group).
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In vivo inhibition of miR-132 in V1 neurons disrupts their ocular dominance plasticity. (a)
Top left: Schematic of experimental design. Top right: Images from confocal microscopy
showing mCherry expression in cortical layers 1-3 at P28 following neonatal injection
(arrow) of mCherry-miR-132 sponge-expressing lentivirus. Bottom: Two-photon
microscope image showing mCherry expression alone (left) and its overlay with OGB
(green) fluorescence (right) in an injected animal that underwent MD; selected neurons used
for (b) are circled and numbered. Scale bars = 40 μm. (b) Example of contralateral and
ipsilateral eye-driven calcium responses of the neurons shown in (a) that express high (top –
neuron 1) or low (bottom - neuron 2) levels of mCherry-miR-132 sponge. Pink shaded area
indicates period with visual stimulus. Calculated ODIs are: 0.73 (top – neuron 1), and 0.55
(bottom – neuron 2). (c) Ocular Dominance Index values (ODI = (contra – ipsi) / (contra +
ipsi); mean ± S.E.M.) derived from peak visual responses obtained by two-photon calcium
imaging in mice injected with mCherry-miR-132 sponge-expressing lentivirus. Black bars
show animals subjected to 4 day MD and light gray bars show animals not subjected to MD:
miR-132 sponge non-MD: 5 animals, 290 neurons; miR-132 sponge MD: 4 animals, 232
neurons; control non-MD: 3 animals, 120 neurons; control MD: 3 animals, 177 neurons.
Note the lack of ODI shift following MD for mice that were injected with miR-132 sponge
but not control virus. Control MD animals show a significantly larger ocular dominance
shift compared to each of the other conditions (P < 0.01, Mann-Whitney test comparing
neurons; P < 0.05 treating each animal as a single datum). (d) Cumulative histogram of ODI
data shown in (c). There is a significant difference between control MD and non-MD
neurons (black and light gray dotted lines respectively), but not between miR-132 sponge-
infected MD and non-MD neurons (black and light gray lines, respectively). P-values shown
are based on Kolmogorov–Smirnov test.
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